关于召开2025年第一次临时股东大会的通知 证券代码：002945 证券简称：华林证券 公告编号：2025-031 华林证券股份有限公司 本公司及公司全体董事会成员保证信息披露的内容真实、准确、 完整，没有虚假记载、误导性陈述或重大遗漏。 华林证券股份有限公司（以下简称"公司"）根据第三届董事会第 二十六次会议决议以及第三届监事会第十四次会议决议，决定召开公司 2025 年第一次临时股东大会（以下简称"本次会议"），现将本次会议 有关事项通知如下： 一、召开会议基本情况 （一）股东大会届次：2025 年第一次临时股东大会 （二）召集人：公司董事会 （三）会议召开的合法、合规性：本次会议的召集、召开符合相关 法律、行政法规、部门规章、规范性文件、深圳证券交易所业务规则及 《公司章程》的规定。 （四）会议召开的日期、时间 1、现场会议召开时间：2025 年 6 月 24 日（周二）14:30 2、网络投票时间：2025 年 6 月 24 日 网络投票系统包括深圳证券交易所交易系统和互联网投票系统 （http://wltp.cninfo.com.cn）。其中： 通过深圳证券交易所交易系统进行网络投票的时间为2025 ...

证券代码：002945 证券简称：华林证券 公告编号：2025-028 华林证券股份有限公司 第三届监事会第十四次会议决议公告 本公司及公司全体监事会成员保证信息披露的内容真实、准确、 完整，没有虚假记载、误导性陈述或重大遗漏。 华林证券股份有限公司（以下简称"公司"）第三届监事会第十四 次会议于 2025 年 6 月 2 日发出书面会议通知（经全体监事一致同意， 豁免本次会议通知期限），并于 2025 年 6 月 6 日完成通讯表决形成 会议决议。本次会议应参加表决监事 3 人，实际参加表决监事 3 人。 会议的召开符合《公司法》和《公司章程》等相关规定。 鉴于公司拟取消监事会设置，原由监事会行使的职责将转由董事 会审计与关联交易委员会履行。在此情形下，《华林证券股份有限公 司监事会议事规则》已失去适用基础，决定予以废止。 为保障公司规范运营，在公司 2025 年第一次临时股东大会决议 生效前，第三届监事会及监事需持续遵循中国证监会、深圳证券交易 所原有规章、规范性文件与业务规则，以及公司现行《公司章程》和 各项规章制度中有关监事会、监事的规定，持续履行监督职责。自股 东大会审议通过取消监事会的决议生效之时 ...

1、《关于提名公司第四届董事会非独立董事候选人的议案》 同意提名林立、张则胜为公司第四届董事会非独立董事候选人。 通过对上述两名非独立董事候选人的教育背景、任职经历、专业能力 和职业素养等情况的审查，上述候选人均具备担任公司非独立董事的 资格，符合担任公司非独立董事任职要求。肖祖发、朱宏因任期届满， 在新一届董事会非独立董事经股东大会选举产生后，将不再担任公司 董事。 证券代码：002945 证券简称：华林证券 公告编号：2025-027 华林证券股份有限公司 第三届董事会第二十六次会议决议公告 本公司及公司全体董事会成员保证信息披露的内容真实、准确、 完整，没有虚假记载、误导性陈述或重大遗漏。 华林证券股份有限公司（以下简称"公司"）第三届董事会第二 十六次会议于 2025 年 6 月 2 日发出书面会议通知（经全体董事一致 同意，豁免本次会议通知期限），并于 2025 年 6 月 6 日在公司会议 室以现场结合视频方式召开。本次会议应出席董事 5 人，实际出席董 事 5 人。本次会议由公司董事长林立先生主持，会议的召开符合《公 司法》和《公司章程》等相关规定。 一、本次会议审议情况 本次会议审议并通过了如 ...

这几只票暗盘资金正在偷偷流入，立即查看>> 券商股异动拉升，华鑫股份（600621）涨停，东吴证券（601555）、锦龙股份（000712）、中国银河 （601881）、光大证券（601788）、华林证券（002945）等跟涨。 ...

Mergers and Acquisitions - Cixing Co., Ltd. plans to acquire 75% of Shenyang Shunyi Technology Co., Ltd. through a combination of issuing shares and cash payments, while also raising supporting funds from no more than 35 qualified investors [1] - United Optoelectronics intends to purchase 100% of Changyi Optoelectronics from 12 shareholders via share issuance and will also raise supporting funds [2] - Inte Group's subsidiary, Inte Pharmaceutical, successfully acquired 100% equity of Zhejiang Huadong Pharmaceutical Group Co., Ltd. for 369 million yuan and signed a transaction contract with the transferor [3] Shareholding Changes - Guokang Biochemical announced that shareholders plan to collectively reduce their holdings by no more than 6% of the company's total shares, with specific plans from two major shareholders to reduce by 3% each [4] - Ruilian New Materials reported that a major shareholder, Guofu Yongyu, plans to reduce its holdings by up to 3.33%, equivalent to 573,110 shares [5] - Hongxin Technology disclosed that two major shareholders, Baiqiang and Taizhou Qixin, plan to reduce their holdings by 2.62% and 2.12% respectively [6] Risk Matters - Sinovac Biotech highlighted the high-tech, high-risk, and high-value characteristics of its innovative drugs, emphasizing the uncertainties involved in the research and approval processes [7] - Zhongheng Design noted that the revenue from its low-altitude economy and commercial aerospace projects is minimal compared to its consolidated financial statements, despite winning several contracts in these sectors [8] Restructuring - *ST Xinyan announced that it received a notice from a creditor applying for the company's restructuring and pre-restructuring procedures [10]

Financial Performance Summary - In 2024, the total revenue of Xiangying Technology reached 873 million yuan, representing a year-on-year increase of 27.95% [1][2] - The net profit attributable to shareholders decreased to 8.06 million yuan, down 61.06% compared to the previous year [1][2] - The net profit after deducting non-recurring gains and losses was 2.10 million yuan, a decline of 88.21% year-on-year [1][2] - The net cash flow from operating activities was 27.53 million yuan, showing a slight increase of 4.02% [1][2] Quarterly Performance Overview - In Q1 2025, the total revenue was 16.66 million yuan, a decrease of 3.40% year-on-year [3] - The net profit attributable to shareholders surged to 4.97 million yuan, an increase of 689.47% compared to the same period last year [3] - The net profit after deducting non-recurring gains and losses was 500.51 thousand yuan, recovering from a loss of 2.38 million yuan in the previous year [3] - The net cash flow from operating activities reached 11.49 million yuan, up 41.98% year-on-year [3] Asset and Equity Status - As of the end of 2024, total assets amounted to 1.36 billion yuan, an increase of 10.11% from the previous year [2] - The net assets attributable to shareholders were 843.64 million yuan, a slight decrease of 1.01% [2] - By the end of Q1 2025, total assets decreased to 1.16 billion yuan, down 14.35% from the end of 2024 [3] IPO and Fundraising Information - Xiangying Technology raised a total of 643 million yuan during its IPO, with a net amount of 583 million yuan after deducting issuance costs [4] - The company initially planned to raise 350 million yuan, but the final net amount exceeded the original plan by 232 million yuan [4] - The funds raised are intended for expansion projects and working capital [4] Convertible Bond Issuance - On September 10, 2024, Xiangying Technology announced plans to issue convertible bonds with a total amount not exceeding 270 million yuan [5] - The proceeds from the bond issuance will be allocated to the construction of a production base in Vietnam, a research and development center, and to supplement working capital [5]

Core Insights - The digital transformation in wealth management is centered around brokers enhancing their app platforms to create a new online service ecosystem [1][4] - In April, the total active users of securities apps reached 167 million, marking a year-on-year increase of 14.29% [2][4] - The trend of upgrading app functionalities, particularly through AI technologies, is becoming a focal point for brokers [3][4] Group 1: Market Activity - The A-share market has seen increased activity, with 9.4 million new accounts opened in the first four months of the year, a year-on-year growth of 31.51% [2] - In April, 11 brokers had apps with over 5 million monthly active users, with Huatai Securities' "Zhangle Wealth" leading at 11.22 million [2][4] - Despite a slight month-on-month decline of 2.7% in active users, the year-on-year growth remains strong [2] Group 2: Technological Advancements - Brokers are focusing on integrating AI and other advanced technologies into their app functionalities to enhance service quality and efficiency [3][4] - Recent updates to apps include features like intelligent investment tools, market tracking, and ETF investment options [3] - The use of AI models is seen as essential for brokers to meet diverse investor needs and improve resource allocation efficiency [4] Group 3: Competitive Landscape - The competition among brokers is intensifying, with a need to differentiate through unique features and services [5] - Brokers are encouraged to leverage user behavior data and AI algorithms to create customized investment solutions [5] - Future developments in broker apps are expected to focus on smart, scenario-based, and diversified services to enhance user engagement [5]

Investment Rating - The report maintains an "Overweight" rating for the securities industry [1] Core Insights - The report emphasizes the importance of a "sustained, stable, and active capital market" as a key driver for market sentiment and growth [6][7] - It highlights the significant growth in the securities industry, particularly in brokerage and proprietary trading, with a notable increase in revenue and net profit for listed brokers in Q1 2025 [36][37] Summary by Sections 1. Policy Interpretation on "Sustained, Stable, and Active Capital Market" - The report discusses recent policy measures aimed at stabilizing and invigorating the capital market, including support for long-term capital inflows and the promotion of new regulatory frameworks [8][7] - It outlines specific actions from the China Securities Regulatory Commission (CSRC) to enhance market liquidity and investor confidence [8] 2. Securities Industry Q1 2025 Performance Overview and Outlook - In Q1 2025, 42 listed brokers achieved revenues of CNY 125.93 billion, a year-on-year increase of 19%, and a net profit of CNY 52.18 billion, up 77.8% [37][38] - The fastest-growing segments were proprietary trading (up 45.5%) and brokerage services (up 43.2%), while investment banking and asset management saw slight declines [36][37] - The report notes that the average return on equity (ROE) for listed brokers improved to 8.05%, reflecting enhanced profitability across the sector [47][46] 3. Investment Recommendations - The report suggests that the ongoing reforms and market conditions present favorable investment opportunities within the securities sector, particularly in brokerage and proprietary trading [36][37] - It identifies potential benefits for underweighted sectors, indicating a shift in investment strategies towards areas with lower current allocations [15]

证券代码：002945 证券简称：华林证券 公告编号：2025-026 华林证券股份有限公司（简称"公司"）第三届董事会、监事会 将于 2025 年 5 月 16 日任期届满。鉴于公司董事会、监事会换届工作 尚在筹备中，为保持董事会、监事会工作的连续性，公司第三届董事 会、监事会需要延期换届选举，公司第三届董事会专门委员会、独立 董事专门会议和高级管理人员的任期亦相应顺延。 在换届选举工作完成之前，公司第三届董事会、监事会全体成员 及高级管理人员将根据相关法律法规和《公司章程》的有关规定继续 履行相应职责。 公司董事会、监事会延期换届不会影响公司的正常运营。公司将 尽快完成董事会、监事会换届选举工作，并及时履行相应的信息披露 义务。 特此公告。 华林证券股份有限公司董事会 华林证券股份有限公司 关于董事会、监事会延期换届选举的提示性公告 本公司及公司全体董事会成员保证信息披露的内容真实、准确、 完整，没有虚假记载、误导性陈述或重大遗漏。 二〇二五年五月十五日 1 ...

中荣股份于2022年10月26日在深交所创业板上市，公开发行股票4,830.00万股，发行价格为26.28元/ 股。中荣股份发行的保荐机构(主承销商)为华林证券（002945）股份有限公司，保荐代表人为陈坚、韩 志强。 上市首日，中荣股份盘中最高报25.28元，创上市以来股价最高点。目前该股处于破发状态。 中国经济网北京5月14日讯中荣股份（301223）(301223.SZ)昨日发布了关于实际控制人、董事长兼总经 理被监视居住的公告。 中荣股份发行募集资金总额为126,932.40万元，扣除发行费用后，募集资金净额为117,827.06万元。中荣 股份最终募集资金净额比原计划多28570.11万元。中荣股份2022年10月17日披露的招股书显示，公司拟 募集资金89,256.95万元，计划用于产能扩建项目、仓库建设项目(昆山)、管理信息系统升级项目(中 山)、偿还银行贷款和补充流动资金。 据中荣股份公告，公司于近日收到公司实际控制人、董事长兼总经理黄焕然家属的通知，黄焕然被中山 市公安局指定居所监视居住。 中荣股份在公告中称，目前，公司已对相关工作进行了妥善安排，除黄焕然外公司其他董事、监事和高 级管理人员 ...